Here's a Quick Look Into the Fundamentals of Tenet Healthcare Stock

By Kim Brooks • Friday, April 21 10:36 • Permanent Link

Shares of Medical Care Facility company Tenet Healthcare jumped 6.2% today. With many investors piling into THC without a second thought, it may be a good idea to take a closer look at the stock. Here are some quick facts to get you started:

Tenet Healthcare has moved -9.6% over the last year, and the S&P 500 logged a change of -3.3%
THC has an average analyst rating of buy and is 34992.5% away from its mean target price of $0.2 per share
Its trailing earnings per share (EPS) is $3.78
Tenet Healthcare has a trailing 12 month Price to Earnings (P/E) ratio of 18.6 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $6.41 and its forward P/E ratio is 10.9
The company has a Price to Book (P/B) ratio of 6.3 in contrast to the S&P 500's average ratio of 2.95
Tenet Healthcare is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
THC has reported YOY quarterly earnings growth of -59.8% and gross profit margins of 0.4%
The company has a free cash flow of $238,875,008.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.